Arca
Skip to content
Tools
Tools

VELYS Robotic-Assisted Solution

Orthopedic Stereotaxic Instrument. 510(k) K240211, from Depuy Ireland UC (Ringaskiddy, Co. Cork, IE). Product code OLO, class 2.

As of Nov 18, 2026, K240211 is an FDA 510(k) held by Depuy Ireland UC, substantially equivalent on Jun 5, 2024 after 132 days, with no recalls tied to it in FDA's recall database.

  • Review time: 132 days
  • Recalls: 0

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The VELYS Robotic-Assisted Solution is intended for stereotaxic surgery to aid the surgeon in identifying the relative position and orientation of anatomical structures, planning the position of the femoral and tibial implant components intraoperatively, and preparing the bones during unicompartmental knee arthroplasty.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other OLO clearances

The newest 510(k)s for the same product code; their median review was 91 days; see every OLO device

Record

Type
Traditional
Received
Jan 25, 2024
Review panel
Neurology
Regulation
21 CFR 882.4560

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.